- Home
- IMCC vs RSLS Comparison
IMCC vs RSLS Comparison
Compare IMCC & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- RSLS
- Stock Information
- Founded
- IMCC 1980
- RSLS 2002
- Country
- IMCC Israel
- RSLS United States
- Employees
- IMCC N/A
- RSLS N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- RSLS Medical/Dental Instruments
- Sector
- IMCC Health Care
- RSLS Health Care
- Exchange
- IMCC Nasdaq
- RSLS Nasdaq
- Market Cap
- IMCC 5.3M
- RSLS 4.5M
- IPO Year
- IMCC N/A
- RSLS 2007
- Fundamental
- Price
- IMCC $2.63
- RSLS $2.45
- Analyst Decision
- IMCC
- RSLS Hold
- Analyst Count
- IMCC 0
- RSLS 1
- Target Price
- IMCC N/A
- RSLS N/A
- AVG Volume (30 Days)
- IMCC 175.7K
- RSLS 7.5M
- Earning Date
- IMCC 08-13-2025
- RSLS 08-13-2025
- Dividend Yield
- IMCC N/A
- RSLS N/A
- EPS Growth
- IMCC N/A
- RSLS N/A
- EPS
- IMCC N/A
- RSLS N/A
- Revenue
- IMCC $37,894,737.00
- RSLS $7,175,000.00
- Revenue This Year
- IMCC $47.12
- RSLS $52.80
- Revenue Next Year
- IMCC $12.83
- RSLS N/A
- P/E Ratio
- IMCC N/A
- RSLS N/A
- Revenue Growth
- IMCC 12.68
- RSLS N/A
- 52 Week Low
- IMCC $1.29
- RSLS $2.23
- 52 Week High
- IMCC $7.12
- RSLS $414.99
- Technical
- Relative Strength Index (RSI)
- IMCC 47.04
- RSLS 36.64
- Support Level
- IMCC $2.67
- RSLS $2.45
- Resistance Level
- IMCC $2.95
- RSLS $2.59
- Average True Range (ATR)
- IMCC 0.37
- RSLS 0.32
- MACD
- IMCC -0.07
- RSLS 0.20
- Stochastic Oscillator
- IMCC 18.98
- RSLS 10.26
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.